Tumor Tissue Microbiota in Colorectal Cancer: PCR Profile of FFPE Blocks in Associations with Metastatic Status
Authors:
- Nikolay K. ShakhpazyanNSNikolay K. Shakhpazyan
- Liudmila M. MikhalevaLMLiudmila M. Mikhaleva
- Nikolay K. SadykhovNSNikolay K. Sadykhov
- Konstantin Y. MidiberKMKonstantin Y. Midiber
- Anton S. BuchakaABAnton S. Buchaka
- Zarina V. GioevaZGZarina V. Gioeva
- Alexander I. MikhalevAMAlexander I. Mikhalev
- Arkady L. BedzhanyanABArkady L. Bedzhanyan
Open Access
Abstract
Background: Tumor-associated microbiota are implicated in colorectal cancer (CRC). Formalin-fixed paraffin-embedded (FFPE) tumor tissue is widely available yet seldom profiled for microbiota. We tested whether quantitative and presence/absence signals of selected taxa in FFPE tumors associate with clinicopathological features. Methods: DNA from FFPE primary CRCs (n = 52) was assayed by a targeted PCR panel quantifying 30 bacterial taxa, Candida spp., and total bacterial load. Presence/absence combinations were selected by the Apriori algorithm with Fisher’s exact testing and 10,000-permutation empirical p-values. Quantitative features were modeled by LASSO logistic regression; discrimination of single taxa and combinations was evaluated by ROC/AUC. Results: In relative-abundance analyses, Fusobacterium nucleatum showed pro-metastatic value (AUC = 0.622). The best absolute-abundance model for metastasis combined F. nucleatum, Faecalibacterium prausnitzii, total bacterial load, and Akkermansia muciniphila (AUC = 0.739). Anti-metastatic directionality in relative-abundance models was driven by Acinetobacter spp.; the two-taxon set Eubacterium rectale + Acinetobacter spp. achieved AUC = 0.747. Conclusions: PCR-based profiling of FFPE CRC tumors is feasible and reveals hypothesis-generating patterns. Signals linking F. nucleatum to metastatic CRC and Acinetobacter spp. to non-metastatic disease merit validation in larger cohorts; tumor-tissue microbiome features may complement clinicopathological assessment.Keywords
Funding Information
- Russian Academy of Sciences (FGFZ-2025-0006 (125021302128-7), FURG-2024-0027 (124021600057-0))
This publication has 29 references indexed in Scilit:
- Gut microbiota in inflammation and colorectal cancer: A potential Toolbox for CliniciansBest Practice & Research Clinical Gastroenterology, 2024
- The Roles of Gut Microbiota Metabolites in the Occurrence and Development of Colorectal Cancer: Multiple Insights for Potential Clinical ApplicationsGastro Hep Advances, 2024
- Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal CancerMicrobiology Spectrum, 2022
- A comprehensive analysis of the microbiota composition and host driver gene mutations in colorectal cancerInvestigational New Drugs, 2022
- Gut microbiome and its role in colorectal cancerBMC Cancer, 2021
- Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancerOncogene, 2020
- Analysis of Fusobacterium persistence and antibiotic response in colorectal cancerScience, 2017
- Faecalibacterium prausnitzii: from microbiology to diagnostics and prognosticsThe ISME Journal, 2017
- Fap2 Mediates Fusobacterium nucleatum Colorectal Adenocarcinoma Enrichment by Binding to Tumor-Expressed Gal-GalNAcCell Host & Microbe, 2016
- Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/β-Catenin Signaling via its FadA AdhesinCell Host & Microbe, 2013